drugset / Trial / NCT00499291

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

NCT00499291

Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This clinical trial is studying how well paclitaxel albumin-stabilized nanoparticle formulation works in treating patients with advanced or refractory solid tumors.

Timeline

Start
2006-09
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule Intravenous

Indications